Check this page often for upcoming PATH Live Forums.
COVID-19 has set back TB eradication by a decade, but it’s also created new opportunities for the adoption of client-centered strategies that could benefit the global TB community in the long term. Join this important dialogue to learn more about how PATH and our partners are adapting to the pandemic to protect—and perhaps, even accelerate—TB progress in the long term.
Artificial intelligence has promising potential for health innovation, but the risks could easily outweigh the rewards. How can we ensure that frontier technologies move us toward health equity and not away from it? What role should the private sector play in advancing the use of these technologies in health systems? Join us for an important dialogue with leaders from the Novartis Foundation, Microsoft, and more as we explore these questions.
Oxygen is essential therapy for COVID-19 patients struggling to breathe, yet shortages in oxygen supply remain a challenge in low-and middle-income countries because of a web of interrelated issues. Why does oxygen supply disruption happen and how do we solve it? This PATH Live Forum disentangles key challenges impeding access –from demand planning to financing to supply and distribution systems –as well as innovative solutions to solve them for COVID-19 and beyond.
As the world responds to the SARS-CoV-2 virus, solutions are being quickly implemented to solve for the here and now. But health systems must support efforts beyond the pandemic. In this live forum, we explored how thoughtful investments made today can be leveraged not only to respond to COVID-19, but also to mitigate the worst-case scenarios of secondary deaths and morbidity and to lay a foundation for more resilient health systems that are better prepared to withstand future stressors.
As COVID-19 continues to spread around the world, it is changing our conversations about public health, about equity, about social and economic structures and norms. But we cannot forget that globally, we have endured similar hardships before.
In this PATH Live Forum, we looked back in history to consider lessons from a century ago when the 1918 influenza pandemic devastated the United States. Professor Nancy K. Bristow, author of American Pandemic: The Lost Worlds of the 1918 Influenza Epidemic, shared her insights.
Access to quality diagnostic tools is our first line of defense for protecting communities from disease. An extraordinary amount of resources have been mobilized in an attempt to rapidly research, develop, and deploy diagnostic testing for the SARS-CoV-2 virus. However, access to quality diagnostic remains a challenge. Newly developed tests have varying or unknown performance and quality, manufacturing capacity is unable to meet global demand, and lower- and middle-income countries have been priced out of available supply. PATH is monitoring these supply insecurities and the needs of clinicians and health providers around the world and is providing guidance and resources to industry partners and countries in order rapidly address these challenges.
In countries across the world, public health systems have made significant progress towards global goals for ending HIV, tuberculosis (TB), and malaria. Now, faced with COVID-19, these programs are up against new challenges that threaten recent lifesaving gains.
This live forum highlighted ways HIV, TB, and malaria service delivery platforms are being leveraged to support the COVID-19 response while mitigating its impact on delivery of essential health services and protecting frontline health care providers.
With a lens on Senegal, this discussion dives into real-time public health efforts underway to support governments and emergency operations centers as they fight the pandemic.
Speakers:
Dr. Abdoulaye Bousso, Director, Health Emergency Operations Center, Senegal
Ms. Aminatou Sar, Senegal Country Director, PATH
Dr. Linda Venczel, Director, Global Health Security, PATH
In this session, PATH’s two top doctors, who are experts in public health and vaccine research and development, provide an update on the current status of the epidemic, vaccines, and treatments as of April 9, 2020.
Presenters:
Dr. David Fleming, Vice President, Global Health Programs
Dr. David Kaslow, Vice President, Essential Medicines